Abstract
Bone metastasis enrichment factor SHMT2 promotes prostate cancer metastasis and affects immune infiltration through Akt/β-catenin signaling pathway
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have